Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms–mismatch repair (MAPP‐MMR)

Lynch syndrome, also known as hereditary nonpolyposis colon cancer (HNPCC), is the most common known genetic syndrome for colorectal cancer (CRC). MLH1/MSH2 mutations underlie approximately 90% of Lynch syndrome families. A total of 24% of these mutations are missense. Interpreting missense variation is extremely challenging. We have therefore developed multivariate analysis of protein polymorphisms–mismatch repair (MAPP‐MMR), a bioinformatic algorithm that effectively classifies MLH1/MSH2 deleterious and neutral missense variants. We compiled a large database (n>300) of MLH1/MSH2 missense variants with associated clinical and molecular characteristics. We divided this database into nonoverlapping training and validation sets and tested MAPP‐MMR. MAPP‐MMR significantly outperformed other missense variant classification algorithms (sensitivity, 94%; specificity, 96%; positive predictive value [PPV] 98%; negative predictive value [NPV], 89%), such as SIFT and PolyPhen. MAPP‐MMR is an effective bioinformatic tool for missense variant interpretation that accurately distinguishes MLH1/MSH2 deleterious variants from neutral variants. Hum Mutat 29(6), 852–860, 2008. © 2008 Wiley‐Liss, Inc.

[1]  Caridad Llanes Betancourt.  Functional evaluation and the fragile elderly , 2008 .

[2]  J. Stockman,et al.  Prediction of MLH1 and MSH2 Mutations in Lynch Syndrome , 2008 .

[3]  Andrew J. Grimm,et al.  Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR) , 2007, Human mutation.

[4]  G. Parmigiani,et al.  Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomothearapy , 2009, Radiation oncology.

[5]  P. Radice,et al.  A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene. , 2006, Cancer research.

[6]  Harry Campbell,et al.  Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. , 2006, The New England journal of medicine.

[7]  A. Viel,et al.  Germ Line Mutations of Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer Patients with Small Bowel Cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study , 2006, Clinical Cancer Research.

[8]  Xin Huo,et al.  Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair. , 2006, DNA repair.

[9]  J. Hopper,et al.  Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. , 2006, Cancer research.

[10]  J. Stockman.  Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) , 2006 .

[11]  P. Loehrer.  Accuracy of Revised Bethesda Guidelines, Microsatellite Instability, and Immunohistochemistry for the Identification of Patients With Hereditary Nonpolyposis Colorectal Cancer , 2006 .

[12]  Eero Pukkala,et al.  Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. , 2005, Gastroenterology.

[13]  A. de la Chapelle,et al.  Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. , 2005, Gastroenterology.

[14]  A. Sidow,et al.  Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. , 2005, Genome research.

[15]  S. Gruber,et al.  Low Allele Frequency of MLH1 D132H in American Colorectal and Endometrial Cancer Patients , 2005, Diseases of the colon and rectum.

[16]  Ronit Almog,et al.  Statins and the risk of colorectal cancer. , 2005, The New England journal of medicine.

[17]  F. Barany,et al.  Classification of BRCA1 missense variants of unknown clinical significance , 2005, Journal of Medical Genetics.

[18]  F. Couch,et al.  Functional evaluation and cancer risk assessment of BRCA2 unclassified variants. , 2005, Cancer research.

[19]  J. Buerstedde,et al.  CpG dinucleotides in the hMSH2 and hMLHI genes are hotspots for HNPCC mutations , 1996, Human Genetics.

[20]  H. Lynch,et al.  Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). , 2004, Archives of internal medicine.

[21]  P. Peltomäki,et al.  Mutations Associated with HNPCC Predisposition — Update of ICG-HNPCC/INSiGHT Mutation Database , 2004, Disease markers.

[22]  F. Couch,et al.  Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. , 2004, American journal of human genetics.

[23]  F. Collins,et al.  The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer , 2004, Nature Genetics.

[24]  I. M. Jones,et al.  Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. , 2004, Genomics.

[25]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[26]  R. Kucherlapati,et al.  An Msh2 Point Mutation Uncouples DNA Mismatch Repair and Apoptosis , 2004, Cancer Research.

[27]  Bryan Langholz,et al.  Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study , 2004, Breast Cancer Research.

[28]  Prakash Nadkarni,et al.  The Cancer Genetics Network: Recruitment Results and Pilot Studies , 2003, Public Health Genomics.

[29]  A. Wagner,et al.  Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer , 2003, Journal of medical genetics.

[30]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[31]  A. de la Chapelle,et al.  Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. , 2003, American journal of human genetics.

[32]  S. Gruber,et al.  Phenotype of Microsatellite Unstable Colorectal Carcinomas: Well‐Differentiated and Focally Mucinous Tumors and the Absence of Dirty Necrosis Correlate With Microsatellite Instability , 2003, The American journal of surgical pathology.

[33]  P. Gregersen,et al.  BLM Heterozygosity and the Risk of Colorectal Cancer , 2002, Science.

[34]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[35]  M. Loda,et al.  Evaluation of Microsatellite Instability and Updated Version Cited Articles Citing Articles E-mail Alerts Evaluation of Microsatellite Instability and Immunohistochemistry for the Prediction of Germ-line Msh2 and Mlh1 Mutations in Hereditary Nonpolyposis Colon Cancer Families , 2022 .

[36]  S. Henikoff,et al.  Accounting for human polymorphisms predicted to affect protein function. , 2002, Genome research.

[37]  S. Lipkin,et al.  A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families. , 2001, Cancer research.

[38]  R. Fishel,et al.  The Interaction of DNA Mismatch Repair Proteins with Human Exonuclease I* , 2001, The Journal of Biological Chemistry.

[39]  A. Ziogas,et al.  Gene-environment interactions in renal cell carcinoma. , 2001, American journal of epidemiology.

[40]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[41]  A. Horii,et al.  The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1 and hPMS2. , 2001, Nucleic acids research.

[42]  D. Chasman,et al.  Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. , 2001, Journal of molecular biology.

[43]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[44]  J. Parker.  Amino Acid Substitution , 2001 .

[45]  A. Ziogas,et al.  Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. , 2001, Journal of the National Cancer Institute.

[46]  P Bork,et al.  SNP frequencies in human genes an excess of rare alleles and differing modes of selection. , 2000, Trends in genetics : TIG.

[47]  P. Bork,et al.  Towards a structural basis of human non-synonymous single nucleotide polymorphisms. , 2000, Trends in genetics : TIG.

[48]  James R. Eshleman,et al.  Conversion of diploidy to haploidy , 2000, Nature.

[49]  A. Lindblom,et al.  Missense mutations in hMLH1 associated with colorectal cancer , 1999, Human Genetics.

[50]  H. Lynch.  Hereditary nonpolyposis colorectal cancer (HNPCC) , 1999, Cytogenetic and Genome Research.

[51]  R. Fishel,et al.  The Interaction of the Human MutL Homologues in Hereditary Nonpolyposis Colon Cancer* , 1999, The Journal of Biological Chemistry.

[52]  A. Zwinderman,et al.  Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. , 1998, The New England journal of medicine.

[53]  C. Boland,et al.  A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.

[54]  J. Ivanovich,et al.  Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability , 1997, Genes, chromosomes & cancer.

[55]  R. Burt.  Screening of patients with a positive family history of colorectal cancer. , 1997, Gastrointestinal endoscopy clinics of North America.

[56]  K. Kinzler,et al.  Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients , 1996, Nature Medicine.

[57]  D. Evans,et al.  MSH2 sequence variations and inherited colorectal cancer susceptibility. , 1996, European journal of cancer.

[58]  R Levine,et al.  Prevention and early detection of colorectal cancer. , 1992, American family physician.

[59]  A. de la Chapelle,et al.  Hereditary Colorectal Cancer , 2010 .